Add this topic to your myFT Digest for news straight to your inbox
Food and Drug Administration poised to call for outside assessment of Lykos PTSD therapy in test for psychedelics sector
Weight-loss treatments are not the only source of excitement in the pharmaceutical research world
Novo Nordisk, Bill & Melinda Gates Foundation and Wellcome focus on interlinked issues
Experts warn better data is required to drive policy as debilitating condition reduces workforce
IPPR researchers describe government’s laissez-faire approach to public health as a ‘failed experiment’
Employees are being offered the ‘party drug’ through company health schemes as psychedelic-assisted therapy grows in popularity
The curious case of the Hackney Mole Man
Boom in healthcare borrowing prompts warnings from doctors and campaigners
While pandemic risk is low, scientists say urgent investigations into the virus are necessary
Even in the most hostile environments, green spaces have long been a place to dream
An FT special report looking at changes in healthcare, treatments and illness itself
For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value
Caseloads of cancer and other illnesses of ageing are forecast to rise steeply in lower income countries
Agriculture department has banned infected cattle from crossing state borders
Wellcome’s John-Arne Røttingen says divisions risk harming action on pandemic responses and ‘superbugs’
Dentists says ‘punitive targets’ under NHS contract system are stifling delivery across the country
The retailer is right to cut losses and shut its healthcare centres and telehealth operation
Also in today’s newsletter, a new twist in the Science-Based Targets initiative drama
Now is not a time for paranoia but there is a case for extreme vigilance
The FT’s senior science writer tests it out
Health service hindered by ‘behaviours of a modern world’ including gambling and poor diet, argues Richard Meddings
Work and pensions secretary Mel Stride calls for ‘adult conversation’ around making system more sustainable
Cost of settling litigation in US over faulty machines is less than what market had expected
How global warming and deforestation are helping diseases jump from animals to humans and spreading fungal infections, while also fuelling antibiotic-resistant ‘superbugs’. Plus the impact on malaria, Lyme disease and the insurance industry
Damage to habitats and closer contact can help multiple infections jump from wildlife
International Edition